Publication Q&A: ODELAM Rapid Sequence-Independent Detection of Drug Resistance in Isolates of Mycobacterium Tuberculosis
June 2020 – Thurston Herricks shares insights from a recent publication in eLife with contributing authors from the Aitchison Lab at the Center for Global Infectious Disease Research (CGIDR). Read more.
A Strategy to Overcome Group B Streptococcus Infections by Using a Vaccine that Mimics its Toxin
April 2020 – Dr. Lakshmi Rajagopal shares insights from a recent publication in Nature Communications about targeting Group B Streptococcus infections by gaining a greater understanding of the molecules the bacterium produces to cause disease. Read more.
Publication Q&A: BCG Vaccination and Mother-to-Infant Transmission of HIV
November 2019 – Matthew Wood shares insights from a recent publication in The Journal of Infectious Disease with contributing authors from the Sodora Lab at the Center for Global Infectious Disease Research (CGIDR). Read more.
Publication Q&A: Using Artificial Intelligence to Predict Drug Interactions and More Effective Treatments For Tuberculosis
November 2019 – Dr. Shuyi Ma explains how artificial intelligence is helping to predict drug interactions, allowing us to more quickly and efficiently devise new treatment strategies for Tuberculosis. Read more.
How 3D Brain Vessels-On-Chip Can Contribute to Cerebral Malaria Research
September 2019 – Learn more about how a 3D brain microvessel model is helping researchers learn more about cerebral malaria. Read more.
Publication Q&A with Maria Bernabeu
Meta-analysis of Plasmodium falciparum var Signatures Contributing to Severe Malaria in African Children and Indian Adults
June 2019 – Dr. Maria Bernabeu shares insights from a recent publication in mBio with contributing authors from the Smith and Aitchison labs. Read more.
Publication Q&A: Liver Stage Malaria Infection is Controlled by Host Regulators of Lipid Peroxidation
May 2019 – Dr. Alexis Kaushansky shares insights from a recent publication in Cell Death & Differentiation with contributing authors from Kaushansky and Aderem labs at the Center for Global Infectious Disease Research (CGIDR). Read more.
Opportunities for Host-Targeted Therapies for Malaria
January 22, 2019 – Cell Press announces one of the best reviews published in 2018 is from Alexis Kaushansky and her colleagues which describes host factors and dependencies that contribute to malaria pathogenesis during various parasite life cycle stages and their potentials for host-targeted therapies. Read more.
CGIDR Researchers Awarded $17.2 Million Tuberculosis Grant From NIH
Feb. 13, 2018 – The Researchers from the Center for Global Infectious Disease Research (CGIDR) have been awarded a grant from the National Institute of Allergy and Infectious Diseases, one of the U.S. National Institutes of Health, to take a systems-level approach to the critical problem of tuberculosis (TB) infection, specifically focusing on the progression from infection to disease, and variability of treatment. Read more.
ODELAY! Measuring Growth, Cell by Cell
Oct. 1, 2018 – Learn about a unique tool and experimental workflow developed by scientists at the Center for Global Infectious Disease Research to measure the many parameters of cell growth on single cells as they grow into colonies. Read more.
Scientist Reflects on Lessons Learned From Nobel Prize Winner
Oct. 31, 2018 – Dr. Shuyi Ma shares her reaction to the news that her undergraduate mentor became the fifth woman in history to receive the Nobel Prize in Chemistry and shares how her mentor helped shaped her career. Read more.